Literature DB >> 20456698

Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008).

Anne F Eder1, Ross M Herron, Annie Strupp, Beth Dy, Jenni White, Edward P Notari, Roger Y Dodd, Richard J Benjamin.   

Abstract

BACKGROUND: Plasma components from female donors were responsible for most cases of transfusion-related acute lung injury (TRALI) reported to the American Red Cross (ARC) between 2003 and 2005. Consequently, we began preferentially distributing plasma from male donors for transfusion in 2006 and evaluated the effect on reported TRALI cases in the ensuing 2 years. STUDY DESIGN AND METHODS: Suspected TRALI cases reported to the ARC Hemovigilance Program in calendar years (CY) 2006, 2007, and 2008 are described. Any case involving a fatality was also independently reviewed by three ARC physicians and classified as probable TRALI or not TRALI.
RESULTS: The percentage of plasma collected from male donors and distributed for transfusion increased each year from 55% in CY2006 to 79% in CY2007 and 95% in CY2008. Independent medical review of the 77 reported TRALI cases involving a fatality identified 38 cases as probable TRALI. Plasma was the only component transfused in six of these cases in 2006, five in 2007, and zero in 2008. Overall, the analysis of reported fatalities and nonfatal cases demonstrates that TRALI involving only plasma transfusion was significantly reduced in 2008 compared to 2006 (32 vs. 7 cases; odds ratio [OR] = 0.21; 95% confidence interval [CI] = 0.08-0.45), to a level that was no longer different from the rate of TRALI observed for RBC transfusion (4.0 vs. 2.3 per 10(6) distributed components; OR = 1.78; 95% CI = 0.67-4.36).
CONCLUSIONS: Reported TRALI cases from plasma transfusion decreased in 2008 compared to the prior 2 years simultaneously with the conversion to male-predominant plasma for transfusion.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2010        PMID: 20456698     DOI: 10.1111/j.1537-2995.2010.02652.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  33 in total

1.  Transfusion-related acute lung injury: incidence and risk factors.

Authors:  Pearl Toy; Ognjen Gajic; Peter Bacchetti; Mark R Looney; Michael A Gropper; Rolf Hubmayr; Clifford A Lowell; Philip J Norris; Edward L Murphy; Richard B Weiskopf; Gregory Wilson; Monique Koenigsberg; Deanna Lee; Randy Schuller; Ping Wu; Barbara Grimes; Manish J Gandhi; Jeffrey L Winters; David Mair; Nora Hirschler; Rosa Sanchez Rosen; Michael A Matthay
Journal:  Blood       Date:  2011-11-23       Impact factor: 22.113

2.  Contemporary Risk Factors and Outcomes of Transfusion-Associated Circulatory Overload.

Authors:  Nareg H Roubinian; Jeanne E Hendrickson; Darrell J Triulzi; Jerome L Gottschall; Michael Michalkiewicz; Dhuly Chowdhury; Daryl J Kor; Mark R Looney; Michael A Matthay; Steven H Kleinman; Donald Brambilla; Edward L Murphy
Journal:  Crit Care Med       Date:  2018-04       Impact factor: 7.598

3.  Proteomic analyses of human plasma: Venus versus Mars.

Authors:  Christopher C Silliman; Monika Dzieciatkowska; Ernest E Moore; Marguerite R Kelher; Anirban Banerjee; Xiayuan Liang; Kevin J Land; Kirk C Hansen
Journal:  Transfusion       Date:  2011-08-31       Impact factor: 3.157

4.  Detection of Nicotine and Nicotine Metabolites in Units of Banked Blood.

Authors:  Joesph R Wiencek; Eric A Gehrie; Amaris M Keiser; Penny C Szklarski; Kamisha L Johnson-Davis; Garrett S Booth
Journal:  Am J Clin Pathol       Date:  2019-04-02       Impact factor: 2.493

Review 5.  The accumulation of lipids and proteins during red blood cell storage: the roles of leucoreduction and experimental filtration.

Authors:  Christopher C Silliman; Timothy Burke; Marguerite R Kelher
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

6.  Identification of lipids that accumulate during the routine storage of prestorage leukoreduced red blood cells and cause acute lung injury.

Authors:  Christopher C Silliman; Ernest E Moore; Marguerite R Kelher; Samina Y Khan; Lauren Gellar; David J Elzi
Journal:  Transfusion       Date:  2011-05-26       Impact factor: 3.157

Review 7.  Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use.

Authors:  Americo Cicchetti; Alexandra Berrino; Marina Casini; Paola Codella; Giuseppina Facco; Alessandra Fiore; Giuseppe Marano; Marco Marchetti; Emanuela Midolo; Roberta Minacori; Pietro Refolo; Federica Romano; Matteo Ruggeri; Dario Sacchini; Antonio G Spagnolo; Irene Urbina; Stefania Vaglio; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2016-07       Impact factor: 3.443

8.  Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).

Authors:  Markus B Funk; Margarethe Heiden; Peter Volkers; Annette Lohmann; Brigitte Keller-Stanislawski
Journal:  Transfus Med Hemother       Date:  2015-05-05       Impact factor: 3.747

9.  Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.

Authors:  Marguerite R Kelher; Anirban Banerjee; Fabia Gamboni; Cameron Anderson; Christopher C Silliman
Journal:  Transfusion       Date:  2016-09-25       Impact factor: 3.157

10.  Prospective study on the clinical course and outcomes in transfusion-related acute lung injury*.

Authors:  Mark R Looney; Nareg Roubinian; Ognjen Gajic; Michael A Gropper; Rolf D Hubmayr; Clifford A Lowell; Peter Bacchetti; Gregory Wilson; Monique Koenigsberg; Deanna C Lee; Ping Wu; Barbara Grimes; Philip J Norris; Edward L Murphy; Manish J Gandhi; Jeffrey L Winters; David C Mair; Randy M Schuller; Nora V Hirschler; Rosa Sanchez Rosen; Michael A Matthay; Pearl Toy
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.